Century Therapeutics, Inc.IPSCNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-2.8%
5Y CAGR+17.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-2.8%/yr
Annual compound
5Y CAGR
+17.6%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $89.34M | -16.7% |
| 2024 | $107.24M | +15.7% |
| 2023 | $92.71M | -4.6% |
| 2022 | $97.17M | +28.5% |
| 2021 | $75.65M | +90.6% |
| 2020 | $39.68M | +178.2% |
| 2019 | $14.27M | - |